CA2492417A1 - Formulation destinee aux femmes en periode de menopause - Google Patents

Formulation destinee aux femmes en periode de menopause Download PDF

Info

Publication number
CA2492417A1
CA2492417A1 CA002492417A CA2492417A CA2492417A1 CA 2492417 A1 CA2492417 A1 CA 2492417A1 CA 002492417 A CA002492417 A CA 002492417A CA 2492417 A CA2492417 A CA 2492417A CA 2492417 A1 CA2492417 A1 CA 2492417A1
Authority
CA
Canada
Prior art keywords
menopausal women
formulation
premenopausal
menopause
relief
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002492417A
Other languages
English (en)
Other versions
CA2492417C (fr
Inventor
R. Saul Levinson
Marc S. Hermelin
Mitchell I. Kirschner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/409,059 external-priority patent/US6479545B1/en
Application filed by Individual filed Critical Individual
Priority to CA002645397A priority Critical patent/CA2645397A1/fr
Publication of CA2492417A1 publication Critical patent/CA2492417A1/fr
Application granted granted Critical
Publication of CA2492417C publication Critical patent/CA2492417C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002492417A 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause Expired - Fee Related CA2492417C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002645397A CA2645397A1 (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/409,059 1999-09-30
US09/409,059 US6479545B1 (en) 1999-09-30 1999-09-30 Formulation for menopausal women
CA002385854A CA2385854C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002385854A Division CA2385854C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002645397A Division CA2645397A1 (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Publications (2)

Publication Number Publication Date
CA2492417A1 true CA2492417A1 (fr) 2001-04-12
CA2492417C CA2492417C (fr) 2008-12-02

Family

ID=34378561

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002492417A Expired - Fee Related CA2492417C (fr) 1999-09-30 2000-08-28 Formulation destinee aux femmes en periode de menopause

Country Status (1)

Country Link
CA (1) CA2492417C (fr)

Also Published As

Publication number Publication date
CA2492417C (fr) 2008-12-02

Similar Documents

Publication Publication Date Title
CA2385854A1 (fr) Formulation destinee aux femmes en periode de menopause
BG101193A (en) New substituted oxazolidinons
ZA200108083B (en) Compositions for improving fertility.
CA2243056A1 (fr) Articles absorbants extensibles
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
ZA977102B (en) Compositions of plant carbohydrates as dietary supplements.
AU7072200A (en) Fast-acting formulation components, compositions and laundry methods employing same
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
WO2000066528A3 (fr) Novel quinones utilisees dans le traitements de maladies
WO2001040177A3 (fr) Esters de vitamine d3 et utilisation de ces ceux-ci
CA2198195A1 (fr) Contenant avec composantes lyophilisees de vaccin
CA2372720A1 (fr) Glycosides d'androgenes et activite androgenique desdits glycosides
WO2000040232A3 (fr) Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires
CA2419471A1 (fr) Utilisation de sulfones de triazinetrione pour lutter contre la coccidiose
CA2263846A1 (fr) Nouveaux derives de pyranoside
PL352104A1 (en) Oral composition containing perlite
AU2001274422A1 (en) Compositions based on aminoacids, suitable for improving muscle performance
WO1999012945A3 (fr) Derives de glycosylamine hydrophobes, compositions a base de ces derives et procedes d'utilisation
CA2284030A1 (fr) Composition polymere, sa preparation, et sa transformation ulterieure en recipients
MY121043A (en) Pharmaceutical compositions
CA2370125A1 (fr) Preparations cosmetiques de maquillage
WO1999048851A3 (fr) Procedes de preparation d'intermediaires
AU3890400A (en) Ionomer composite compositions
WO2002098438A1 (fr) Compositions contenant une fraction active isolee de scutellariae barbatae, et methodes d'utilisation
AU7655600A (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed